Ustekinumab en situaciones especiales: embarazo, interrupciones temporales (vacunaciones, cirugía) y otros
Ustekinumab in special situations: pregnancy, temporal interruptions (vaccinations, surgery) and others
R. Rivera
, F. Vanaclocha
Autor para correspondencia
Servicio de Dermatología. Hospital Universitario 12 de Octubre. Madrid. España
Leído
6188
Vecesse ha leído el artículo
3041
Total PDF
3147
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 65 | 110 | 175 |
| 2025 5 | 60 | 58 | 118 |
| 2025 4 | 59 | 38 | 97 |
| 2025 3 | 53 | 29 | 82 |
| 2025 2 | 54 | 37 | 91 |
| 2025 1 | 27 | 28 | 55 |
| 2024 12 | 32 | 30 | 62 |
| 2024 11 | 30 | 49 | 79 |
| 2024 10 | 38 | 35 | 73 |
| 2024 9 | 27 | 22 | 49 |
| 2024 8 | 45 | 62 | 107 |
| 2024 7 | 40 | 30 | 70 |
| 2024 6 | 57 | 38 | 95 |
| 2024 5 | 33 | 36 | 69 |
| 2024 4 | 34 | 35 | 69 |
| 2024 3 | 29 | 37 | 66 |
| 2024 2 | 27 | 35 | 62 |
| 2024 1 | 22 | 24 | 46 |
| 2023 12 | 39 | 27 | 66 |
| 2023 11 | 33 | 23 | 56 |
| 2023 10 | 33 | 18 | 51 |
| 2023 9 | 39 | 31 | 70 |
| 2023 8 | 27 | 23 | 50 |
| 2023 7 | 32 | 28 | 60 |
| 2023 6 | 39 | 24 | 63 |
| 2023 5 | 20 | 16 | 36 |
| 2023 4 | 29 | 20 | 49 |
| 2023 3 | 71 | 23 | 94 |
| 2023 2 | 30 | 19 | 49 |
| 2022 1 | 38 | 26 | 64 |
| 2022 12 | 29 | 37 | 66 |
| 2022 11 | 34 | 44 | 78 |
| 2022 10 | 36 | 28 | 64 |
| 2022 9 | 27 | 35 | 62 |
| 2022 8 | 32 | 38 | 70 |
| 2022 7 | 36 | 45 | 81 |
| 2022 6 | 24 | 33 | 57 |
| 2022 5 | 30 | 36 | 66 |
| 2022 4 | 40 | 44 | 84 |
| 2022 3 | 27 | 58 | 85 |
| 2022 2 | 26 | 31 | 57 |
| 2021 1 | 40 | 43 | 83 |
| 2021 12 | 21 | 40 | 61 |
| 2021 11 | 32 | 42 | 74 |
| 2021 10 | 35 | 49 | 84 |
| 2021 9 | 21 | 49 | 70 |
| 2021 8 | 32 | 49 | 81 |
| 2021 7 | 38 | 40 | 78 |
| 2021 6 | 33 | 38 | 71 |
| 2021 5 | 49 | 43 | 92 |
| 2021 4 | 63 | 48 | 111 |
| 2021 3 | 43 | 42 | 85 |
| 2021 2 | 27 | 23 | 50 |
| 2020 1 | 32 | 22 | 54 |
| 2020 12 | 16 | 25 | 41 |
| 2020 11 | 15 | 24 | 39 |
| 2020 10 | 30 | 17 | 47 |
| 2020 9 | 7 | 25 | 32 |
| 2020 8 | 24 | 19 | 43 |
| 2020 7 | 18 | 17 | 35 |
| 2020 6 | 22 | 32 | 54 |
| 2020 5 | 29 | 34 | 63 |
| 2020 4 | 17 | 22 | 39 |
| 2020 3 | 20 | 24 | 44 |
| 2020 2 | 31 | 5 | 36 |
| 2020 1 | 0 | 8 | 8 |
| 2019 12 | 0 | 6 | 6 |
| 2019 11 | 1 | 8 | 9 |
| 2019 10 | 0 | 7 | 7 |
| 2019 9 | 0 | 4 | 4 |
| 2019 8 | 0 | 9 | 9 |
| 2019 7 | 0 | 14 | 14 |
| 2019 6 | 0 | 20 | 20 |
| 2019 5 | 0 | 59 | 59 |
| 2019 4 | 1 | 28 | 29 |
| 2019 3 | 0 | 3 | 3 |
| 2019 2 | 0 | 4 | 4 |
| 2019 1 | 0 | 1 | 1 |
| 2018 12 | 0 | 4 | 4 |
| 2018 11 | 0 | 1 | 1 |
| 2018 10 | 0 | 2 | 2 |
| 2018 9 | 0 | 5 | 5 |
| 2018 8 | 0 | 27 | 27 |
| 2018 7 | 0 | 4 | 4 |
| 2018 6 | 0 | 5 | 5 |
| 2018 5 | 0 | 8 | 8 |
| 2018 4 | 0 | 6 | 6 |
| 2018 3 | 0 | 5 | 5 |
| 2018 2 | 23 | 11 | 34 |
| 2018 1 | 20 | 11 | 31 |
| 2017 12 | 31 | 17 | 48 |
| 2017 11 | 26 | 13 | 39 |
| 2017 10 | 17 | 34 | 51 |
| 2017 9 | 18 | 25 | 43 |
| 2017 8 | 19 | 18 | 37 |
| 2017 7 | 15 | 15 | 30 |
| 2017 6 | 23 | 22 | 45 |
| 2017 5 | 24 | 19 | 43 |
| 2017 4 | 28 | 22 | 50 |
| 2017 3 | 23 | 12 | 35 |
| 2017 2 | 29 | 31 | 60 |
| 2016 1 | 30 | 17 | 47 |
| 2016 12 | 30 | 15 | 45 |
| 2016 11 | 34 | 16 | 50 |
| 2016 10 | 39 | 11 | 50 |
| 2016 9 | 35 | 32 | 67 |
| 2016 8 | 31 | 12 | 43 |
| 2016 7 | 21 | 5 | 26 |
| 2016 6 | 0 | 6 | 6 |
| 2016 5 | 0 | 14 | 14 |
| 2016 4 | 0 | 1 | 1 |
| 2016 3 | 0 | 3 | 3 |
| 2016 2 | 0 | 4 | 4 |
| 2015 1 | 0 | 11 | 11 |
| 2015 12 | 1 | 6 | 7 |
| 2015 11 | 6 | 10 | 16 |
| 2015 10 | 4 | 10 | 14 |
| 2015 9 | 9 | 10 | 19 |
| 2015 8 | 8 | 9 | 17 |
| 2015 7 | 42 | 2 | 44 |
| 2015 6 | 51 | 8 | 59 |
| 2015 5 | 61 | 22 | 83 |
| 2015 4 | 48 | 19 | 67 |
| 2015 3 | 44 | 11 | 55 |
| 2015 2 | 25 | 10 | 35 |
| 2015 1 | 20 | 14 | 34 |
| 2014 12 | 38 | 8 | 46 |
| 2014 11 | 30 | 14 | 44 |
| 2014 10 | 33 | 23 | 56 |
| 2014 9 | 1 | 1 | 2 |
| 2014 6 | 1 | 0 | 1 |
| 2014 5 | 1 | 0 | 1 |
| 2014 3 | 1 | 0 | 1 |
| 2014 1 | 0 | 1 | 1 |
| 2013 9 | 1 | 2 | 3 |
| 2013 7 | 1 | 1 | 2 |
| 2013 6 | 1 | 6 | 7 |
| 2013 4 | 1 | 1 | 2 |
| 2013 2 | 3 | 4 | 7 |
| 2013 1 | 0 | 2 | 2 |
Mostrar todo
